Copper and antibiotics: discovery, modes of action, and opportunities for medicinal applications

AG Dalecki, CL Crawford, F Wolschendorf - Advances in microbial …, 2017 - Elsevier
Copper is a ubiquitous element in the environment as well as living organisms, with its redox
capabilities and complexation potential making it indispensable for many cellular functions …

Targeting Phenotypically Tolerant Mycobacterium tuberculosis

B Gold, C Nathan - Tuberculosis and the Tubercle Bacillus, 2017 - Wiley Online Library
Two parallel revolutions were born in the golden era of antibiotics (~ 1940 to 1960). One
was a revolution in medicine as physicians went to war with microbes. The second was a …

Novel antimicrobial 8-hydroxyquinoline-based agents: Current development, structure–activity relationships, and perspectives

AR Joaquim, MP Gionbelli, G Gosmann… - Journal of Medicinal …, 2021 - ACS Publications
The search for new antimicrobials is imperative due to the emergent resistance of new
microorganism strains. In this context, revisiting known classes like 8-hydroxyquinolines …

Overview of the development of DprE1 inhibitors for combating the menace of tuberculosis

RV Chikhale, MA Barmade, PR Murumkar… - Journal of medicinal …, 2018 - ACS Publications
Decaprenylphosphoryl-β-d-ribose 2′-epimerase (DprE1), a vital enzyme for cell wall
synthesis, plays a crucial role in the formation of lipoarabinomannan and arabinogalactan. It …

Oxidative phosphorylation as a target space for tuberculosis: success, caution, and future directions

GM Cook, K Hards, E Dunn, A Heikal… - Tuberculosis and the …, 2017 - Wiley Online Library
The genus Mycobacterium comprises a group of obligately aerobic bacteria that have
adapted to inhabit a wide range of intracellular and extracellular environments …

Mycobacterium Tuberculosis (MTB) GyrB inhibitors: An attractive approach for develo** novel drugs against TB

K Chaudhari, S Surana, P Jain, HM Patel - European journal of medicinal …, 2016 - Elsevier
New classes of drugs are needed to treat tuberculosis (TB) in order to combat the
emergence of resistance (MDR and XDR) to existing agents and shorten the duration of …

Novel targets in M. tuberculosis: search for new drugs

G Lamichhane - Trends in molecular medicine, 2011 - cell.com
The recent past has experienced a renaissance in tuberculosis (TB) research. New
molecular biology reagents and genetic tools have been developed and whole genome …

Salicylanilide derivatives block Mycobacterium tuberculosis through inhibition of isocitrate lyase and methionine aminopeptidase

M Krátký, J Vinšová, E Novotná, J Mandíková, V Wsól… - Tuberculosis, 2012 - Elsevier
The global burden of tuberculosis, its health and socio-economic impacts, the presence of
drug-resistant forms and a potential threat of latent tuberculosis should serve as a strong …

2, 4-Disubstituted thiazoles as multitargated bioactive molecules

P Arora, R Narang, SK Nayak, SK Singh… - Medicinal chemistry …, 2016 - Springer
Thiazoles are important heterocyclics exhibiting boundaryless biological activities, such as
antibacterial, antifungal, anti-inflammatory, antitumor, antitubercular, antidiabetic, antiviral …

Targeting Non-Replicating Mycobacterium tuberculosis and Latent Infection: Alternatives and Perspectives (Mini-Review)

A Egorova, EG Salina, V Makarov - International Journal of Molecular …, 2021 - mdpi.com
Latent tuberculosis infection (LTBI) represents a major challenge to curing TB disease.
Current guidelines for LTBI management include only three older drugs and their …